55 results about "Media otitis" patented technology

The invention relates to the technical field of medicines, in particular to novel application of orifice-opening and deafness-removing pills in preparation of anti-dizziness medicines. Experiments prove that the administration group can remarkably shorten the standing time consumption of a vertigo mouse caused by movement on the horizontal rod and reduce the vertigo response index, so that the movement vertigo model mouse can stand stably on the horizontal rod more quickly; abnormal changes of indexes such as ACTH, NE and CREB in mouse serum and BDNF, CREB, 5-HT and DA in brain caused by motion vertigo can be remarkably reversed. Therefore, the orifice-opening and deafness-removing pill has an obvious anti-dizziness effect, can be used as an active ingredient for preparing the anti-dizziness medicine, and is an effective treatment medicine especially for dizziness induced by movement. According to the invention, new indications of the orifice-opening and deafness-removing pill except deafness, tinnitus and otitis media are expanded. In anti-dizziness treatment, compared with dizziness stop, the traditional Chinese medicine composition can avoid digestive system reaction, cardiovascular reaction, central nervous system reaction and other side effects caused by dizziness stop.

Disclosed herein are systems and methods for classifying a tympanic membrane by using a classifier. The classifier is a machine learning algorithm. A method for classifying a tympanic membrane includes steps of: receiving, from an interrogation system, one or more datasets relating to the tympanic membrane; determining a set of parameters from the one or more datasets, wherein at least one parameter of the set of parameters is related to a dynamic property or a static position of the tympanic membrane; and outputting a classification of the tympanic membrane based on a classifier model derived from the set of parameters. The classification comprises one or more of a state, a condition, or a mobility metric of the tympanic membrane.

The invention relates to an antibacterial hydrogel, which is a gel formed by taking chitosan quaternary ammonium salt as a component and contains protocatechualdehyde. It is verified that the antibacterial hydrogel is good in biocompatibility and high in safety, has the capabilities of resisting bacteria, resisting generation of bacterial biofilms, resisting inflammation, resisting oxidation and the like and immunoregulatory activity, can play a good acute otitis media treatment effect in a local administration mode, is low in drug resistance, facilitates reduction of abuse of antibiotics, and has a good application prospect. Infection and recurrence are effectively prevented, and a novel, safe and ideal treatment method is provided for clinical decision-making of acute otitis media patients. The gel is prepared into an ear drop dosage form, does not flow out after being dropped into the ear canal, and is convenient to take.

An ultrasound signal processor uses an excitation generator to cause displacement of a tympanic membrane while a series of ultrasound pulses are applied to the tympanic membrane. Phase differences between a transmitted signal and received signal are examined to determine the movement of the tympanic membrane in response to the applied excitation. An examination of the phase response of the tympanic membrane provides a determination as to whether the fluid type behind the tympanic membrane is one of: no fluid, serum fluid, or purulent fluid.

The invention discloses an application of a streptococcus salivarius subsp. Thermophilus Biohalo 23 tablet in preparation of a product for treating otitis media. The preservation number of the streptococcus salivarius subsp. Thermophilus Biohalo 23 is DSM34540; the streptococcus salivarius subsp. Thermophilus Biohalo 23 tablet can relieve the disease symptoms of otitis media and reduce the morbidity of the otitis media, has a remarkable curative effect on the otitis media, and particularly, through clinical tests, the number of diseases of infants can be remarkably reduced, the morbidity of the infants can be reduced, middle ear effusion can be improved, and the curative effect of the infants on the otitis media can be improved. Therefore, the streptococcus salivarius subsp. Thermophilus Biohalo 23 tablet disclosed by the invention can be used for treating the otitis media.

1. The name of the product of this design: Tympanic membrane perforation measuring ruler. 2. Purpose of the product of this design: used to measure the size of eardrum perforation caused by otitis media and trauma. 3. The design key point of this appearance design product lies in the shape. 4. The picture or photo that best illustrates the design points: three-dimensional picture.

The embodiment of the invention provides a clinical intervention decision-making method and device, electronic equipment and a storage medium, and belongs to the technical field of artificial intelligence. The method comprises the steps that secretory otitis media clinical data of a to-be-evaluated user are acquired, and the secretory otitis media clinical data comprise multiple etiological clinical features; obtaining a target secretory otitis media disease probability prediction model; on the basis of a target secretory otitis media disease probability prediction model, performing feature evaluation on the clinical features of the multiple etiologies to obtain multiple user feature scores; based on the target secretory otitis media disease probability prediction model and the plurality of user feature scores, performing disease probability prediction on the to-be-evaluated user to obtain user disease prediction data; and based on the user disease prediction data, performing clinical intervention decision on the to-be-evaluated user. According to the application, the secretory otitis media can be effectively prevented, the accuracy of clinical intervention decisions can be improved, and in addition, the treatment effect of the secretory otitis media can be effectively evaluated.

To provide an ultrasound transducer and a method.SOLUTION: An ultrasound transducer may include: a plurality of capacitive ultrasound transducer elements; and a base having a maximum dimension sized and shaped to be disposed within an external ear canal, the plurality of capacitive ultrasound transducers being mounted on the base. Each capacitive ultrasound transducer element and the ultrasound transducer are specifically constructed to achieve select desired performance characteristics. The ultrasound transducer may have an angular beam spread through a gaseous medium of greater than 15 degrees and an attenuation loss through the gaseous medium of greater than 10 dB measured at a distance 12.5 mm to 25 mm along a primary transmission axis of the ultrasound transducer. The ultrasound transducer may be particularly useful for characterizing fluid behind an ear drum to diagnose otitis media.SELECTED DRAWING: Figure 6A

This invention discloses a wearable ultrasound delivery device for treating otitis media, comprising a wearable main body with a flexible structure adapted to the shape of the patient's ear canal, and a through-hole central channel; an ultrasound drug delivery device, detachably disposed within the central channel, comprising a drug carrier for carrying the therapeutic drug to be delivered, an ultrasound transducer assembly for providing an ultrasound-guided drug delivery mode, and a handheld controller for adjusting the millimeter-level displacement of the drug carrier into the middle ear cavity; wherein, the ultrasound transducer assembly comprises a flexible substrate and multiple piezoelectric transducer units integrated on the flexible substrate, the multiple piezoelectric transducer units constituting a phased array transducer array. This device solves the technical problems of inaccurate drug delivery, low drug delivery efficiency, inability to adapt to the ear canal structure, and complex operation in the prior art.

A system for assessing AOM includes a computing device having a processor apparatus, wherein the processor apparatus implements a diagnostic classifier component that comprises a. trained neural network, the processor apparatus being structured and configured to receive tympanic membrane image data representing one or more images of a tympanic membrane of the patient, provide the tympanic membrane image data to the diagnostic classifier component, and process the tympanic membrane image data in the diagnostic classifier component to determine: (i) a plurality of tympanic membrane features from the tympanic membrane image data, (ii) a diagnosis of whether the patient has AOM based on the plurality of tympanic membrane features, (iii) a. confidence in the diagnosis, and (iv) an identification one or more of the tympanic membrane features determined to be predominant contributing features that led to the diagnosis.

The invention discloses an ear drop for treating otitis media and a preparation method thereof in the technical field of otitis media treatment, and the ear drop comprises the following raw materials in parts by weight: 10-60 parts of coptis chinensis, 5-20 parts of boric acid, 6-20 parts of borneol and 600-1300 parts of boiling water. According to the invention, coptis chinensis has a good treatment effect on inflammation and infection caused by otitis media, boric acid has astringency and antibacterial effects and can effectively reduce auditory meatus secretions and promote inflammation regression, and borneol can relieve pain and discomfort caused by otitis media; and by using boiling water, effective components of the medicinal materials are fully extracted in the preparation process, and meanwhile, the concentration and viscosity of the ear drops are adjusted, so that the ear drops are more suitable for the auditory meatus environment, the irritation of the ear drops is reduced, and meanwhile, the volatilization time of the ear drops in the ears of a patient is shortened.

The invention is related to 26-valent immunogenic compositions comprising 26 different S. pneumoniae polysaccharide carrier protein conjugates, wherein each of the conjugates comprises a polysaccharide from an S. pneumoniae serotype conjugated to a carrier protein, wherein the serotypes of S. pneumoniae are as defined herein. The 26-valent immunogenic compositions are useful for providing protection against S. pneumoniae infection and / or pneumococcal diseases caused by S. pneumoniae including pneumococcal pneumoniae, invasive pneumococcal disease and acute otitis media.

The present invention relates to a middle ear inflammation treatment device. Disclosed is a middle ear inflammation treatment device installed with a ventilation tube, the device comprising: a handle; a cutting sheath connected to the handle and having a tubular shape with an inner diameter greater than an outer diameter of the ventilation tube, and wherein the ventilation tube is inserted into the cutting sheath; and a suction tube formed to be relatively movable to the cutting sheath in a length direction of the cutting sheath within the cutting sheath, wherein the suction tube has a tubular shape to suck and remove exudate in a middle ear through the suction tube; and a moving tool located outside the handle and relatively moving the suction tube to the cutting sheath.

The invention discloses an imbedding ventilation pipe device for treating otitis media. The embedded ventilation pipe device for treating otitis media comprises a shell, the shell is in a hollow pipe shape, a guide part is arranged in the shell, the guide part is in a hollow pipe shape, a prefabricated part is arranged at the first end of the guide part, the prefabricated part is arranged at the first end in the shell, a ventilation pipe is arranged in the prefabricated part, and the ventilation pipe is arranged in the shell. And the second end part of the prefabricated part abuts against the first end part of the guide part. The defects of an existing surgical instrument are overcome to a certain degree, the surgical instrument is integrated, the surgical success probability is improved, and the device is better suitable for clinical use, convenient to operate, capable of shortening the surgical time and suitable for minimally invasive surgery.

The utility model provides an adjuvant therapy device for eliminating eosinophilic otitis media, which comprises a major component and an auxiliary component, the major component comprises a main control handle, a power pump, a main operating rod and a main working probe, and a function switching knob is rotatably mounted on the rear side of the upper end of the main control handle. Compared with the prior art, the otitis media treatment device has the following advantages that due to the arrangement of the main treatment assembly and the auxiliary assembly, in actual use, when a doctor removes otitis media of an acidophilic otitis media patient, the otitis media treatment device can be used for treating otitis media of the acidophilic otitis media patient, and therefore the otitis media treatment device can be used for treating otitis media of the acidophilic otitis media patient. The double hands of a doctor can carry out operation work simultaneously, namely, medicine injection after left hand puncture and right hand suction of effusion in the tympanic chamber, so that the tedious operation that the left hand holds an otoscope or an otoendoscope and the right hand sequentially carries out medicine injection and medicine suction in a traditional operation is changed, repeated dilution and extraction are not needed, the operation duration is greatly shortened, and the discomfort of a patient is reduced.

The invention relates to an intelligent otitis media regulation and control method and device. The method comprises the steps that a negative electrode needle and a positive electrode needle of otitis media regulation and control equipment are connected to an intelligent regulation and control interface module; the negative electrode needle is guided by an endoscope to enter the nasal cavity of the subject; an endoscopic image is analyzed through an MSFFN positioning algorithm and a DAN model of the intelligent regulation and control interface module, preliminary image recognition is performed through the MSFFN positioning algorithm to capture multi-scale features, and treatment positions of a negative electrode needle and a positive electrode needle are learned through the DAN model; the negative electrode needle and the positive electrode needle are controlled by the intelligent treatment control interface module to be inserted into a predetermined treatment position learned by the DAN model after being in place; connecting the positive electrode needle to otitis media regulation and control equipment; and the electrode needle is positioned and adjusted through an ARNN treatment control model of the intelligent treatment control interface module. The electrode needle is intelligently controlled and adjusted through the intelligent treatment control interface module and the ARNN treatment control model, and treatment individuation and effectiveness are improved.

The invention discloses a suction device for treating otitis media of children, and belongs to the technical field of treatment of otitis media of children. The suction device is provided with a fixing spring, a connecting sleeve, a suction catheter, a fixing needle sleeve and a clamping sleeve, and after a fixing clamping block on the inner wall of the clamping sleeve corresponds to an arc-shaped clamping groove in position, the fixing needle sleeve is inserted into the arc-shaped clamping groove; a connecting sleeve is loosened, a first moving block is jacked up to reset in a strip-shaped mounting groove under the springback effect of a fixed spring, the connecting sleeve is driven to move from the surface of the mounting sleeve to the surface of a clamping sleeve, and meanwhile, the connecting sleeve extrudes the clamping sleeve, so that the clamping sleeve is clamped on the surface of a fixed needle sleeve until a fixed clamping block is clamped into an annular clamping groove; meanwhile, a connecting sleeve is tightly attached to a limiting stop block, so that the inner wall of the connecting sleeve extrudes a second rubber clamping ring, the connecting sleeve is clamped and fixed to the surface of a clamping clamping sleeve, and it is guaranteed that when the suction needle head stretches into the auditory meatus of the child for suction treatment, the fixing needle sleeve cannot fall off from the surface of the suction catheter randomly due to struggling of the child.

Provided is an otological liquid or the like for preventing and / or treating otitis externa and / or otitis media, which contains, as an active ingredient, 10-20 mg of levofloxacin, a pharmaceutically acceptable salt thereof, or a solvate of the levofloxacin or the pharmaceutically acceptable salt in 1 ml.

The invention discloses a chronic otitis media CT report automatic generation system based on a visual-language large model, and belongs to the technical field of radiation medicine. The system comprises a data acquisition and processing module for acquiring image data and text data and preprocessing the data; the vision-language large model training module is used for inputting the preprocessed data into a vision-language large model for training and adjusting and optimizing model parameters; and the report generation interaction module is used for generating a structured report by utilizing the trained vision-language large model. According to the system, the visual-language large model is applied to the field of CT report generation and typing diagnosis of chronic otitis media for the first time, the technical blank in the field is filled, and a new path is developed for intelligent diagnosis of chronic otitis media.

The embodiment of the application discloses an otological image intelligent identification method based on a multi-modal artificial intelligence, and comprises the following steps: acquiring an otological image and clinical text information of a patient; fusing the otological image and the clinical text information to obtain multi-modal features; and identifying the multi-modal clinical text information features by using a multi-model integrated architecture to automatically determine the tympanic membrane state of the patient, wherein the tympanic membrane state comprises a normal tympanic membrane, a perforation, an inward protrusion, an effusion, a suppurative otitis media, calcification and otosclerosis. The embodiment realizes automatic intelligent identification of the tympanic membrane state.

An ultrasound signal processor uses an excitation generator to cause displacement of a tympanic membrane while a series of ultrasound pulses are applied to the tympanic membrane. Phase differences between a transmitted signal and received signal are examined to determine the movement of the tympanic membrane in response to the applied excitation. An examination of the phase response of the tympanic membrane provides a determination as to whether the fluid type behind the tympanic membrane is one of: no fluid, serum fluid, or purulent fluid.

Systems and methods for classifying tympanic membranes by using a classifier are disclosed herein. The classifier is a machine learning algorithm. A method of classifying a tympanic membrane includes the steps of: receiving one or more data sets related to the tympanic membrane from an interrogation system; determining a set of parameters from the one or more data sets, wherein at least one parameter in the set of parameters is related to a dynamic property or a static position of the tympanic membrane; and outputting a classification of the tympanic membrane based on a classifier model derived from the set of parameters. The classification includes one or more of a state, condition, or mobility metric of the tympanic membrane.

An ultrasonic transducer can include a plurality of capacitive ultrasonic transducer elements and a base having a maximum dimension sized and shaped to be disposed within an external ear canal, wherein the plurality of capacitive ultrasonic transducer elements are mounted on the base. Each capacitive ultrasonic transducer element and the ultrasonic transducer are specifically constructed to achieve selected desired performance characteristics. The ultrasonic transducer can have an angular beam that propagates through a gaseous medium that is greater than 15 degrees and an attenuation loss through the gaseous medium that is greater than 10 dB measured at a distance of 12.5 mm to 25 mm along a primary transmission axis of the ultrasonic transducer. The ultrasonic transducer can be particularly useful for characterizing fluid behind a tympanic membrane to diagnose otitis media.

Provided is an otitis media treatment instrument and, more particularly, to an otitis media treatment instrument having a ventilation tube installed thereon, the otitis media treatment instrument including: a cutting sheath which is configured in a tube shape, and which has an inner diameter larger than the outer diameter of the ventilation tube; and a suction pipe formed to be able to move relative to the cutting sheath inside the cutting sheath along the longitudinal direction of the cutting sheath, the suction pipe having, on the front end portion thereof, an insertion portion having an outer diameter smaller than the inner diameter of the ventilation tube and having a fixing portion which extends toward the front end of the insertion portion, and which has an outer diameter larger than the inner diameter of the ventilation tube.

An ultrasound transducer may include: a plurality of capacitive ultrasound transducer elements; and a base having a largest dimension sized and shaped to be disposed with an external ear canal, wherein the plurality of capacitive ultrasound transducers is mounted on the base. Each capacitive ultrasound transducer element and the ultrasound transducer are specifically constructed to achieve select desired performance characteristics. The ultrasound transducer may have an angular beam spread through a gaseous medium of greater than 15 degrees and an attenuation loss through the gaseous medium of greater than 10 dB measured at a distance 12.5 mm to 25 mm along a primary transmission axis of the ultrasound transducer. The ultrasound transducer may be particularly useful for characterizing fluid behind an ear drum to diagnose otitis media.

The utility model belongs to the technical field of medical nursing materials, and particularly relates to a device for preventing water from entering an ear canal after a child otitis media operation, which comprises an earmuff used for wrapping the ear of a child, the inner end of the earmuff is provided with a containing protection cavity used for containing the ear of the child, and the earmuff is provided with a reinforcing sheet, a first waterproof adhesive and a protection cover. The ear protection cover is used for covering the outer end of the ear of a child patient, the ear of the child patient can be effectively protected, liquid is prevented from entering the ear canal of the child patient to cause the infection phenomenon, the ear canal of the child patient can be protected, and the ear canal of the child patient can be protected from being infected. Meanwhile, due to the arrangement of the double waterproof mucilage glue, the fixing effectiveness and the waterproof performance can be further improved, and the situation that normal use of the waterproof function is affected due to the fact that the double waterproof mucilage glue falls off is prevented.

Disclosed herein are systems and methods for classifying a tympanic membrane using a classifier. The classifier is a machine learning algorithm. A method for classifying a tympanic membrane comprises the following steps: receiving one or more data sets related to the tympanic membrane from a medical consultation system; determining a set of parameters from the one or more data sets, wherein at least one parameter in the set of parameters is related to a dynamic property or a static position of the tympanic membrane; and outputting a classification of the tympanic membrane based on a classifier model derived from the set of parameters. The classification includes one or more of a state, a condition, or a mobility metric of the tympanic membrane.

According to the construction method and application of the acute otitis media Bama miniature pig model, the acute otitis media Bama miniature pig model which is easy to operate, high in success rate, typical in symptom and high in postoperative survival rate is established, and the acute otitis media Bama miniature pig model is used for research on acute otitis media pathogenesis and treatment schemes. And a new way is provided for the treatment research of acute otitis media.

Provided are topically administered pharmaceutical compositions for the treatment of fungal infected eye and ear diseases, such as fungal keratitis, otitis externa or otitis media caused by fungal infection, and methods of making the same. The pharmaceutical composition comprises a triazole antifungal agent as an active ingredient, a non-aqueous solvent and an optional tension regulator, and can be a non-aqueous composition without preservatives. The non-aqueous composition has one or more of the following advantages: the non-aqueous composition is high in stability, free of preservatives and low in irritation, the concentration of antifungal drugs in local tissues is increased, the toxic and side effects of the whole body are reduced, the residence time of the antifungal drugs in the local tissues is prolonged, the administration frequency is reduced, and the compliance of patients is improved.

A composition includes a therapeutic compound, a liposome shell, and a pharmaceutically acceptable carrier comprising a stimuli-responsive hydrogel encapsulating the therapeutic compound. The liposome shell includes a plurality of hydroxyl-containing lipids.